Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
<strong>Aims<br></strong> Robust diabetes risk estimates in Asian patients with impaired glucose tolerance (IGT) and coronary heart disease (CHD) are lacking. We developed a Chinese type 2 diabetes risk calculator using Acarbose Cardiovascular Evaluation (ACE) trial data. <br>...
Những tác giả chính: | Xu, S, Scott, CAB, Coleman, RL, Tuomilehto, J, Holman, RR |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Wiley
2021
|
Những quyển sách tương tự
-
Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
Bằng: Xu, S, et al.
Được phát hành: (2019) -
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
Bằng: Wamil, M, et al.
Được phát hành: (2020) -
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
Bằng: Leal, J, et al.
Được phát hành: (2022) -
People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
Bằng: Califf, R, et al.
Được phát hành: (2003) -
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
Bằng: Currie, G, et al.
Được phát hành: (2017)